BioCryst Pharmaceuticals, Inc. 3Y Shareholders Equity Growth (per Share)

3Y Shareholders Equity Growth (per Share) of BCRX for past 10 years: annual, quarterly and twelve month trailing (TTM) including 3Y Shareholders Equity Growth (per Share) growth rates and interactive chart.


Highlights and Quick Summary

  • Annual 3Y Shareholders Equity Growth (per Share) for 2021 was 0.0% (a NaN% decrease from previous year)
  • Annual 3Y Shareholders Equity Growth (per Share) for 2020 was 0.0% (a -100.0% decrease from previous year)
  • Annual 3Y Shareholders Equity Growth (per Share) for 2019 was 149.13% (a -1591.3% decrease from previous year)
Visit stockrow.com/BCRX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical 3Y Shareholders Equity Growth (per Share) of BioCryst Pharmaceuticals, Inc.

Most recent 3Y Shareholders Equity Growth (per Share)of BCRX including historical data for past 10 years.

Interactive Chart of 3Y Shareholders Equity Growth (per Share) of BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. 3Y Shareholders Equity Growth (per Share) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 0.0%
2020 0.0%
2019 149.13%
2018 -10.0%
2017 -4.33%
2016 0.0%
2015 0.0%
2014 51.15%
2013 0.0%
2012 0.0%

Business Profile of BioCryst Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology